The effects of mirabegron on obesity‐induced inflammation and insulin resistance are associated with brown adipose tissue activation but not beiging in the subcutaneous white adipose tissue-Reference-Cited by-同舟云学术

The effects of mirabegron on obesity‐induced inflammation and insulin resistance are associated with brown adipose tissue activation but not beiging in the subcutaneous white adipose tissue

Published:2021-08-15 Issue:11 Volume:48 Page:1477-1487
ISSN:0305-1870
Container-title:Clinical and Experimental Pharmacology and Physiology
language:en
Short-container-title:Clin Exp Pharmacol Physiol

Author:

Peres Valgas da Silva Carmem¹²³^ORCID,Calmasini Fabiano⁴,Alexandre Eduardo Costa⁴,Raposo Helena Fonseca⁵,Delbin Maria Andreia⁵^ORCID,Monica Fabiola Zakia⁴,Zanesco Angelina³⁶

Affiliation:

1. Dorothy M. Davis Heart and Lung Research Institute The Ohio State University Wexner Medical Center Columbus OH USA

2. Department of Physiology and Cell Biology The Ohio State University Wexner Medical Center Columbus OH USA

3. Department of Physical Education Institute of Biosciences São Paulo State University (UNESP) Rio Claro Brazil

4. Department of Pharmacology Faculty of Medical Sciences University of Campinas (UNICAMP) Campinas Brazil

5. Department of Structural and Functional Biology Institute of Biology University of Campinas (UNICAMP) Campinas Brazil

6. Medical School Graduate Program in Environmental Health Metropolitan University of Santos Santos Brazil

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1440-1681.13566

Reference57 articles.

1. Obesity and Prevalence of Cardiovascular Diseases and Prognosis—The Obesity Paradox Updated

2. Overnutrition, ectopic lipid and the metabolic syndrome

3. Targeting autophagy in obesity: from pathophysiology to management

4. Implications of thermogenic adipose tissues for metabolic health

5. Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the protective potential of mirabegron against thioacetamide-induced hepatic encephalopathy in rats: Insights into cAMP/PPAR-γ/p-ERK1/2/p S536 NF-κB p 65 and p-CREB/BDNF/TrkB in parallel with oxidative and apoptotic trajectories;Biochemical Pharmacology;2024-11

2. Role of cAMP/pCREB and GSK-3β/NF-κB p65 signaling pathways in the renoprotective effect of mirabegron against renal ischemia-reperfusion injury in rats;European Journal of Pharmacology;2024-07

3. Mirabegron alleviates fructose induced nonalcoholic fatty liver disease in rats: Insights into the underlying mechanisms;Pharmacological Research - Reports;2024-03

4. β3 adrenergic receptor activation alleviated PM2.5-induced hepatic lipid deposition in mice;Science of The Total Environment;2024-01

5. Mirabegron, a Selective β3-Adrenergic Receptor Agonist, as a Potential Anti-Obesity Drug;Journal of Clinical Medicine;2023-11-02